financetom
Business
financetom
/
Business
/
Lucid Stock Is Sliding Monday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lucid Stock Is Sliding Monday: What's Going On?
Nov 3, 2025 9:22 AM

Lucid Group Inc ( LCID ) is trading lower Monday afternoon as shares pull back from momentum following strategic announcements last week. The EV maker recently unveiled two major partnerships, signaling a deep push into autonomous driving.

LCID is taking a hit from negative sentiment. View the charts here.

What To Know: Last week, Lucid partnered with Nvidia to integrate the DRIVE AGX Thor platform, which will accelerate its path to delivering Level 4 autonomous vehicles.

Following the autonomous initiative update, the company announced a major collaboration with Uber and Nuro to develop a next-generation autonomous robotaxi service. The first robotaxis are expected to be available on the Uber app in 2026.

The autonomous news flow comes just before Lucid reports its third-quarter earnings, which are scheduled for Wednesday after the market close. Analysts are forecasting a quarterly loss of $2.26 per share and revenue of $352.62 million.

Recent analyst ratings have shown increased optimism. In September, Cantor Fitzgerald maintained a Buy rating while raising its price target to $26, and Morgan Stanley increased its target to $30, suggesting confidence in the company’s long-term vision.

Benzinga Edge Rankings: A key statistic from Benzinga Edge Rankings highlights Monday’s move lower, showing Lucid with a weak Momentum score of 10.90.

LCID Price Action: Lucid Group ( LCID ) shares were down 6.14% at $16.66 at the time of publication on Monday, according to Benzinga Pro data.

Read Also: Stock Market Today: S&P 500, Dow Jones Futures Rise After Stellar October Gains

How To Buy LCID Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Lucid Group’s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Life Time Opens Final Athletic Country Club of 2024 in Minnesota
Life Time Opens Final Athletic Country Club of 2024 in Minnesota
Dec 27, 2024
11:09 AM EST, 12/27/2024 (MT Newswires) -- Life Time Group Holdings ( LTH ) said Friday it has opened its final athletic country club of this year in Minnesota. The 90,000-square-foot Life Time Rosemount club is the company's 28th location in the state, it added. Shares of the company were down 2% in recent Friday trading. Price: 21.71, Change: -0.49,...
Outlook Therapeutics' Annual Loss Per Share Narrows in FY24; Shares Up
Outlook Therapeutics' Annual Loss Per Share Narrows in FY24; Shares Up
Dec 27, 2024
10:57 AM EST, 12/27/2024 (MT Newswires) -- Shares of Outlook Therapeutics ( OTLK ) were up Friday after the biopharmaceutical company reported a loss of $4.06 per share for fiscal 2024, narrowing from a loss of $4.72 a year earlier. Six analysts surveyed by FactSet estimated a loss of $4.91 per share. The company didn't report any revenue for the...
PayPal Holdings Unusual Options Activity For December 27
PayPal Holdings Unusual Options Activity For December 27
Dec 27, 2024
Investors with a lot of money to spend have taken a bullish stance on PayPal Holdings ( PYPL ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this...
Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules
Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules
Dec 27, 2024
NEW YORK, Dec 27 (Reuters) - A U.S. appeals court on Friday revived a whistleblower lawsuit accusing the Swiss drugmaker Novartis of paying illegal kickbacks to doctors to induce them to promote its blockbuster multiple sclerosis drug Gilenya. In a 3-0 decision, the 2nd U.S. Circuit Court of Appeals in Manhattan said the whistleblower Steven Camburn can try to prove...
Copyright 2023-2026 - www.financetom.com All Rights Reserved